New pathogenic paradigms in inflammatory bowel disease

Antonio Di Sabatino, Paolo Biancheri, Laura Rovedatti, Thomas T. MacDonald, Gino R. Corazza

Research output: Contribution to journalArticlepeer-review


Recent progresses in basic science have opened new pathogenic scenarios in inflammatory bowel disease. The T helper cell type (Th)1/Th2 paradigm has been outdated thanks to the advances in understanding the function of Th17 cells. Innate immunity, nonimmune cells, and defective tolerogenic mechanisms play a no less crucial role than do adaptive immunity, immune cells, and hyperactivation of effector mechanisms. These new paradigms, together with the no longer "static" but "dynamic" vision of intestinal inflammation, highlight new possible therapeutic targets in inflammatory bowel disease.

Original languageEnglish
Pages (from-to)368-371
Number of pages4
JournalInflammatory Bowel Diseases
Issue number2
Publication statusPublished - Feb 2012


  • Crohn's disease
  • cytokines
  • mucosal immunology
  • T cell
  • ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy


Dive into the research topics of 'New pathogenic paradigms in inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this